TP53 and cancer: Anti-angiogenic activity of emodin is also associated with its ability to induce apoptosis through the p53-dependent pathway [62], whereas overexpression of p53 and interaction of this protein with kinase signaling may contribute to inhibition of VEGF synthesis in cancer cells [63].